Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.
Saved in:
| Title: | Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors. |
|---|---|
| Authors: | Chow LQ; University of Washington, Seattle Cancer Care Alliance, MSG4-940, 825 Eastlake Ave E, Box 358081, Seattle, WA, 98109, USA. lchow@seattlecca.org., Smith DC; University of Michigan, Ann Arbor, MI, USA., Tan AR; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Denlinger CS; Fox Chase Cancer Center, Philadelphia, PA, USA., Wang D; Henry Ford Hospital, Detroit, MI, USA., Shepard DR; Cleveland Clinic Foundation, Cleveland, OH, USA., Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA., Lin Y; Eli Lilly and Company, Indianapolis, IN, USA., Gao L; Eli Lilly and Company, Bridgewater, NJ, USA. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 433-41. Date of Electronic Publication: 2016 Jul 05. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-016-3098-3 |
